A New Hope in Alzheimer's Treatment; Lecanemab

Lecanemab's apparent effectiveness follows years of disillusionment with earlier, comparable medications that were meant to delay or stop the course Alzheimer's disease. It contains monoclonal antibodies created in laboratories goal purging brain a material called as beta-amyloid, exactly like lot those other medicines. People disease tend have an accumulation beta-amyloid their brains, which leads development sticky plaques come be associated condition. As result this, objective his research paper is investigate background information about drug lecanemab. In addition study offers regarding approval procedure for lecanemab, drug's mode action, and, lastly, most recent discoveries.